IMPROVEMENT OF CELLULAR IMMUNITY AND IgA PRODUCTION IN IMMUNODEFICIENT CHILDREN AFTER TREATMENT WITH SYNTHETIC SERUM THYMIC FACTOR (FTS)
- 1 August 1982
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 320 (8293) , 293-297
- https://doi.org/10.1016/s0140-6736(82)90271-9
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Circulating thymic hormone activity in patients with primary and secondary immunodeficiency diseasesThe American Journal of Medicine, 1981
- Immature IGA B Cells in IGA-Deficient PatientsNew England Journal of Medicine, 1981
- T-cell suppression of immunoglobulin synthesis in ataxia telangiectasia: Restriction of suppressor activity to B cells from unrelated donorsClinical Immunology and Immunopathology, 1981
- Immunologic and Clinical Investigation on a Bovine Thymic Extract. Therapeutic Applications in Primary ImmunodeficienciesPediatric Research, 1979
- A Synthetic Pentapeptide with Biological Activity Characteristic of the Thymic Hormone ThymopoietinScience, 1979
- Thymic HormonesJournal of Immunopharmacology, 1979
- Suppressor cells and IgA deficiencyClinical Immunology and Immunopathology, 1978
- Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other EBV antigens in Chinese patientsInternational Journal of Cancer, 1975
- ROLE OF SUPPRESSOR T CELLS IN PATHOGENESIS OF COMMON VARIABLE HYPOGAMMAGLOBULINÆMIAThe Lancet, 1974
- DIFFERENTIATION OF T CELLS INDUCED BY PREPARATIONS FROM THYMUS AND BY NONTHYMIC AGENTSThe Journal of Experimental Medicine, 1973